ThinkstockThe drug and pharmaceutical sector is supposed to be a defensive one by nature, even if this week’s government shutdown and impending debt ceiling weighed heavily on biotech stocks. Credit Suisse’s Vamil…
Jon OggInvestors and traders alike are stuck trying to determine what to do with their stocks during a government shutdown and ahead of the debt ceiling debate. Each morning 24/7 Wall St.…
ThinkstockMerck & Co. (NYSE: MRK) announced it would rid itself of 8,500 workers, many of whom work in the big pharmaceutical company’s R&D operations. Since the return on research investment at Merck…
ThinkstockThe number of companies paying dividends in the S&P 500 is at a 15-year high. According to FactSet, just over 80 companies in the index do not pay dividends. Paying dividends has…
ThinkstockDrugmaker Merck & Co. Inc. (NYSE: MRK) announced Tuesday morning that it will fire another 8,500 employees in an effort to “sharpen” the company’s focus on R&D and returns to shareholders. The…
Paul Ausick ThinkstockShort sellers have increased their bets against the stable high-dividend stocks that are in most Americans’ retirement accounts and mutual funds. In fact, the mid-September short interest saw year highs in many…
Wikimedia CommonsChances are high that you already have heard that the Dow Jones Industrial Average (DJIA) is making a serious change among its 30 constituents. What you might not have heard outside of…
Jon OggShort sellers are trying to decide what to do when it comes to how evaluate the high-yield dividend and defensive stocks. The latest short interest changes as of July 31 are compared…
ThinkstockMerck & Co. Inc. (NYSE: MRK) is seeing one more drug drive off the patent cliff. News was released on Monday by Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) that it and Perrigo Co.…
courtesy of Wal-Mart Stores Inc.Companies can return capital to shareholders in many ways. Dividends are one of the favored methods. So is retiring outstanding debt, as it decreases the amount of capital…
ThinkstockShort sellers are continuing to keep their bets against many of the top defensive high-yield dividend stocks. Increased volatility in June and rising interest rates are obviously making short sellers get aggressive…
Short sellers are continuing to keep their bets against many of the top defensive high-yield dividend stocks. Increased volatility in June and rising interest rates are obviously making short sellers get aggressive…
ThinkstockAlthough Amgen Inc.’s (NASDAQ: AMGN) $10 billion offer for Onyx Pharmaceuticals Inc. (NASDAQ: ONXX) was unsolicited and not exactly a stalking horse bid, that’s what many observers expect to be the result.…
Short sellers have really made some big changes in their bets against the key high-yield dividend stocks that had been the darling of Wall Street. Many of these stocks are members of…
Short sellers could have cleaned up by betting against the high dividend stocks in May and into June. Investors got a whiff of what rising interest rates might mean to their premium…
